Login / Register The Most Trusted Name in Medical Education

Geriatric Medicine

Find the latest continuing medical courses in the managed care of adult patients. These activities are designed to meet the educational needs of health care professionals who are involved with the care of adult patients.

910729 116 x 140

CHEST 2017: AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN COPD

Format: Conference Reporter

The CHEST Annual Meeting 2017 was held in Toronto, Ontario, Canada, October 28–November 1, 2017. As the premier chest medicine education meeting for clinicians, CHEST unites leaders to discuss current pulmonary, critical care, and sleep medicine topics. In this activity, 2 experts summarize the key learnings from this year’s Annual Meeting, focusing on chronic obstructive pulmonary disease (COPD).

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit™
910732 116 x 140 2

STRENGTH IN NUMBERS: A TEAM-BASED APPROACH TO MANAGING PATIENTS WITH HYPONATREMIA

Format: Webcast

These virtual patient panels provide learners with real-world application of best practices among various members of the healthcare team in the management of patients with hyponatremia. A patient case is provided, followed by discussion among the team members to provide insight and context to why particular courses of action were chosen.

Take Course »

 

Credits: 0.50 AMA PRA Category 1 Credit(s)™, per course
910758 116 x 140

AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN IDIOPATHIC PULMONARY FIBROSIS

Format: Conference Reporter

The European Respiratory Society (ERS) International Congress 2017 was held in Milan, Italy, September 9-13, 2017. The Congress has been a platform for improving standards in respiratory medicine and putting the spotlight on respiratory care. In this activity, 2 experts summarize the key learnings from this year’s Congress focusing on Idiopathic Pulmonary Fibrosis (IPF).

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit™
910701 116 x 144

Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

Format: Webcast Series

This CME-accredited CME Snapshot™ educational series, Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care is intended for primary care clinicians and other health care providers involved in the ongoing management of patients with chronic obstructive pulmonary disease (COPD). Within each focused activity, an expert pulmonologist and a primary care educator discuss best practices for a specific aspect of managing patients with COPD, including monitoring the disease course over time, maximizing patient function, and individualizing treatment regimens. One activity also addresses patients’ perspectives by incorporating patient-clinician interactions and insights into disease burdens, challenges to good long-term outcomes, and shared decision-making. 

Take Course »

 

Credits: Up to 1.00 AMA PRA Category 1 Credit(s)™
910730 116 x 141

CONFRONTING THE CHALLENGE OF COPD: WHAT IS NEW IN THE APPROACHES TO DIAGNOSIS, TREATMENT, AND PATIENT OUTCOMES

Format: Webcast

Most aspects of chronic obstructive pulmonary disease (COPD) have been undergoing renewed scrutiny in recent years, with research investigating the entire spectrum of disease development and progression, the genetic phenotypes and risk factors, disease heterogeneity, refinements in diagnostic approaches, advances in treatment options, and so forth. This activity provides insights into new approaches to identifying patients with undiagnosed COPD, the importance of early initiation of pharmacologic treatment in a guideline-congruent manner, and the importance of repeated patient training in correct inhaler technique in order to improve adherence and patient outcomes.

 

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit(s)™
116x140 RGNRN ATS ASTHMA2

CLINICAL ISSUES IN SEVERE ASTHMA: CONSENSUS AND CONTROVERSIES ON THE ROAD TO PRECISION MEDICINE

Format: Webcast

This CME-accredited Clinical IssuesTM program is intended for allergists/clinical immunologists, pulmonologists, and other healthcare providers involved in the management of patients with severe asthma. During the activity, a panel of expert faculty discuss and debate a series of topics related to the evaluation and long-term treatment of various severe asthma phenotypes. Activity topics include classification of severe asthma, disease biomarkers, comorbidity management, and current and emerging targeted biologic therapies. The goal is to provide clinician learners with the latest evidence and a fresh perspective on evolving management paradigms for severe asthma.

 

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit(s)™
910739 116 x 140

AAIC 2017: AN UPDATE ON SCIENTIFIC ADVANCES AND CLINICAL STRATEGIES IN ALZHEIMER’S DISEASE FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE®

Format: Conference Reporter

The Alzheimer’s Association International Conference® 2017 (AAIC®) was held in London, England, July 16-20, 2017. As the largest international meeting dedicated to advancing dementia science, AAIC unites leaders from more than 70 countries to discuss the latest dementia study results and theories. In this activity, 2 experts summarize the key learnings from this year’s conference.

 

Take Course »

 

 

Credits: 0.75 AMA PRA Category 1 Credit(s)™
910687 116x140

Severe Asthma and the Primary Care Provider: Identifying Patients and Coordinating Multidisciplinary Care

Format: Webcast

This CME-accredited Through Your Patient’s EyesTM program is intended for primary care providers and other clinicians who manage patients with asthma. This educational activity has been designed to highlight issues faced by people living with asthma, including patients’ perspectives on the burdens of severe disease, difficulties related to suboptimal health literacy, and potential hurdles that can arise in busy healthcare practices. Specialist and primary care faculty discuss practical advice on overcoming these challenges, how to best coordinate multidisciplinary care, and actionable recommendations on identifying, comprehensively assessing, and longitudinally managing patients with severe asthma. As a result, clinician learners will be better prepared to engage and educate their patients with severe asthma, while improving long-term outcomes through personalized evidence-based care.  

Take Course »

 

Credits: 1.00 AMA PRA Category 1 Credit(s)™ or 1.00 Nursing Contact Hours
910728 116 x 140

An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive Pulmonary Disease (COPD) from the ATS 2017 International Conference

Format: Conference Reporter

The 2017 American Thoracic Society (ATS) International Conference was held in Washington, DC, May 19–24, 2017. As a leading meeting in respiratory medicine, dedicated to advancing the clinical and scientific understanding of pulmonary diseases, critical illnesses, and sleep-related breathing disorders, the ATS Conference attracts thousands of participants from around the world. The 2017 ATS conference featured 6700 original research projects, 500 sessions, and 800 speakers. In this activity, 2 experts summarize the key learnings on COPD from this year’s conference.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™
thumbnail

Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability

Format: Webcast

Effective treatment of major depressive disorder with antidepressants is currently limited by factors that affect treatment compliance, including delay in onset of therapeutic effects and, often, intolerable side-effects. Recent data suggest that use of antidepressant combinations with different mechanisms of action may be a better first-line strategy prior to augmentation with other drug classes. The rationale for this approach is that combining multiple pharmacological actions affecting multiple monoamine targets produces greater efficacy. The latest data on multimodal therapies indicate shorter onset of therapeutic effects and improved tolerability. By modulating multiple receptors and neurotransmitter systems, it is hoped that these new agents may also treat some of the associated symptoms of major depressive disorder, such as anxiety and cognitive dysfunction.

Register»

Credits: 3.0 AMA PRA Category 1 Credits™
910720 116 x 140

An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease: Conference Reporter from AD/PD™ 2017

Format: Conference Reporter

The Alzheimer’s & Parkinson’s Diseases (AD/PD™) 13th International Conference was held in Vienna, Austria, March 29 to April 2, 2017. The conference attracts international medical and scientific professionals worldwide and is at the forefront of unraveling the mechanisms and improving the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD). In this activity, 2 experts summarize the key learnings from this year’s conference focusing on AD.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™
2016 Alzheimers Disease in Primary Care banner116x140

Alzheimer’s Disease in Primary Care: The Significance of Early Detection, Diagnosis, and Intervention

Format: Webcast

The field of Alzheimer’s disease (AD) is undergoing a profound and rapid change: clinical trials have been redesigned to focus on individuals in the earliest stages of the disease and are including more sensitive measurement tools to better capture changes in cognition and other outcomes. Trial participants undergo PET imaging for amyloid load as a hallmark for dementia, as well as genetic testing to determine likelihood of disease progression and response to therapeutic intervention. Large national and international registries have been established to capture those at risk and to follow their development of cognitive changes longitudinally. Understanding that the disease process starts at least a decade or more before the onset of symptoms has prompted the development of therapeutic interventions acting very early in the disease cascade. For all these reasons, recognizing and diagnosing AD early offers affected individuals and their caregivers the best chance for care planning, access to available symptomatic treatment and community resources, as well as involvement with clinical trials and access to new therapies when they become available. Primary care clinicians play a pivotal role in the early recognition of cognitive impairment in their patients.

Take Course »

Credits: 1.00 AMA PRA Category 1 Credit(s)™